Clinical Trial Update: Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating motexafin gadolinium in combination with docetaxel for advanced cancers; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastrointestinal Cancer
• Lung Cancer
• Ovarian Cancer
• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Motexafin Gadolinium (motexafin gadolinium)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Breast Neoplasms, Ovarian Neoplasms | Phase 1 | Status: COMPLETED